English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography

Zander, T., Scheffler, M., Nogova, L., Kobe, C., Engel-Riedel, W., Hellmich, M., et al. (2011). Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. Journal of Clinical Oncology, 29(13), 1701-1708. doi:10.1200/JCO.2010.32.4939.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Zander, Thomas1, Author           
Scheffler, Matthias2, Author
Nogova, Lucia2, Author
Kobe, Carsten2, Author
Engel-Riedel, Walburga2, Author
Hellmich, Martin2, Author
Papachristou, Irini2, Author
Toepelt, Karin2, Author
Draube, Andreas2, Author
Heukamp, Lukas2, Author
Buettner, Reinhard2, Author
Ko, Yon D.2, Author
Ullrich, Roland T.1, Author           
Smit, Egbert2, Author
Boellaard, Ronald2, Author
Lammertsma, Adriaan A.2, Author
Hallek, Michael2, Author
Jacobs, Andreas H.3, Author           
Schlesinger, Andreas2, Author
Schulte, Karin2, Author
Querings, Silvia4, Author           Stoelben, Erich2, AuthorNeumaier, Bernd5, Author           Thomas, Roman K.4, Author           Dietlein, Markus6, Author           Wolf, Juergen2, Author more..
Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
2a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, University Hospital of Cologne, 50924 Cologne, Germany b Clinic for Nuclear Medicine, University Hospital of Cologne, Cologne, Germany c Lung Clinic Merheim, Hospital of Cologne, Cologne, Germany d Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany e Evangelical Hospital Kalk, Cologne, Germany f Hospital Holweide, Cologne, Germany g Institute of Pathology, University Hospital Bonn, Bonn, Germany h Johanniter Hospital Bonn, Bonn, Germany i European Institute of Molecular Imaging, University of Münster, Germany j Vrije University Medical Center Amsterdam, Netherlands, ou_persistent22              
3Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149662              
4Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              
5Radiochemistry, Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149672              
6Translational Neurocircuitry, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149668              

Content

show
hide
Free keywords: -
 Abstract: © 2011 by American Society of Clinical Oncology

Details

show
hide
Language(s): eng - English
 Dates: 2011
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 573353
DOI: 10.1200/JCO.2010.32.4939
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Clinical Oncology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 29 (13) Sequence Number: - Start / End Page: 1701 - 1708 Identifier: ISSN: 0732183X